Similarly, GO analysis illuminated the role of genes in the negative regulation of peptidase activity, with studies indicating Dipeptidase-2's impact on E-cadherin levels, affecting cell migration, cancer stem cell dynamics, and drug resistance, which in turn affects the survival of LUAD patients28. This evidence concerns the gene LAP3 and cancer.